Human Platelet-Derived Growth Factor Enhances Healing of Ulcers Situated on Non-Foot Sites in Diabetics. A Pilot Study

Author(s): Sanjay Kalra, Bharti Kalra

Journal Name: Current Drug Therapy

Volume 7 , Issue 1 , 2012

Become EABM
Become Reviewer
Call for Editor


This prospective, single centre, open –label study assessed the efficacy, efficiency and tolerability of topical recombinant human platelet –derived growth factor (rhPDGF) in the treatment of chronic ulcers at sites other than the foot in 4 patients with diabetes mellitus. RhPDGF gel 0.01% was applied once daily to the target ulcer in these patients. Efficacy was assessed in terms of ulcer size reduction and efficiency as time to complete healing. Safety was assessed in terms of incidence of adverse events. All ulcers healed completely, of which 2 healed within 2 weeks, 1 by 4 weeks, and 1 by 8 weeks.

Keywords: Diabetes, non-foot ulcers, topical rhPDGF, wound healing

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 19 April, 2012
Page: [64 - 66]
Pages: 3
DOI: 10.2174/157488512800389191

Article Metrics

PDF: 70